Skip to main content
Glama

Server Details

Find clinical trials overdue on legally required results reporting, by sponsor and trial.

Status
Healthy
Last Tested
Transport
Streamable HTTP
URL

Glama MCP Gateway

Connect through Glama MCP Gateway for full control over tool access and complete visibility into every call.

MCP client
Glama
MCP server

Full call logging

Every tool call is logged with complete inputs and outputs, so you can debug issues and audit what your agents are doing.

Tool access control

Enable or disable individual tools per connector, so you decide what your agents can and cannot do.

Managed credentials

Glama handles OAuth flows, token storage, and automatic rotation, so credentials never expire on your clients.

Usage analytics

See which tools your agents call, how often, and when, so you can understand usage patterns and catch anomalies.

100% free. Your data is private.
Tool DescriptionsA

Average 4/5 across 1 of 1 tools scored.

Server CoherenceA
Disambiguation5/5

Only one tool exists, so there is no risk of confusion with other tools. The tool's purpose is clearly defined and distinct.

Naming Consistency5/5

With a single tool, naming is trivially consistent. The name 'overdue_trials' follows a clear noun_verb pattern.

Tool Count4/5

One tool is slightly below the typical well-scoped count of 3-15, but it is reasonable for a very narrow domain (filtering overdue trials).

Completeness4/5

The tool covers the primary use case of finding overdue trials with filtering. Minor gaps exist (e.g., no separate tool for detailed trial info), but the core functionality is complete.

Available Tools

1 tool
overdue_trialsAInspect

Find clinical trials whose results are overdue under FDAAA 801 / 42 CFR Part 11 (results due within 1 year of primary completion). Filter by sponsor name or stock ticker. Returns public-record facts from ClinicalTrials.gov — NOT a finding of violation or legal/investment advice.

ParametersJSON Schema
NameRequiredDescriptionDefault
tickerNoStock ticker, e.g. 'BAYRY'
minDaysNoMinimum days overdue
sponsorNoSponsor company name (partial match), e.g. 'Novartis'
Behavior3/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

No annotations are provided, so the description carries the burden. It discloses the source (ClinicalTrials.gov) and the disclaimer, but does not explicitly state read-only nature or other behavioral details like pagination or result format.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Two sentences, front-loaded with main purpose and then caveat. No wasted words.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a simple query tool with 3 parameters and no siblings or output schema, the description provides enough context: what it finds, regulation basis, filters, and a legal disclaimer. Could be more detailed on result handling.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so baseline is 3. The description adds context by stating filters by sponsor or ticker, but does not add significant meaning beyond the schema descriptions for the parameters.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool finds clinical trials overdue under specific regulations and filters by sponsor or ticker. It is specific and unambiguous.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explains what the tool does and includes a disclaimer about not being legal advice, setting expectations. However, no alternative tools are mentioned since no siblings exist.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Discussions

No comments yet. Be the first to start the discussion!

Try in Browser

Your Connectors

Sign in to create a connector for this server.

Resources